S&P 500 Consumer Staples Sector SEC Filings — September 25, 2026

USA S&P 500 Consumer Staples

By Gunpowder Editorial ·

7 high priority 7 total filings analysed

Executive Summary

The seven filings for the Consumer Staples stream are all Form 4 insider ownership filings from The Clorox Company, representing a coordinated, company-wide equity grant to top executives. This cluster of filings, all dated September 25, 2026, reveals a significant and uniform insider accumulation event totaling over $4.3 million in stock awards across the C-suite.

The pattern of awards—proportional to executive seniority—is a strong signal of management alignment and a bullish indicator for the company's long-term strategy. With no sales or option exercises reported, the sentiment is unequivocally positive. This event stands out as a high-conviction signal in a sector where insider buying is often a leading indicator of management confidence. The lack of any other filing types (e.g., 10-K, 8-K) in this batch limits the ability to perform cross-company period-over-period comparisons, but the depth of insider data provides a powerful, singular theme for the digest.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from September 24, 2026.

Investment Signals (8)

  • Clorox (CLX) (BULLISH)
    ▲

    CEO-adjacent leadership (COO, CFO, CLO, CAO) collectively awarded $4.3M in stock at $83.94/share, with zero insider sales. This is a powerful signal of management's long-term conviction and alignment with shareholders.

  • Clorox (CLX) (BULLISH)
    ▲

    The COO (Chris T. Hyder) received the largest single award ($1.12M), the highest materiality score (6/10) in the batch, signaling deep operational confidence and a focus on execution.

  • Clorox (CLX) (BULLISH)
    ▲

    The CFO (Luc Bellet) was awarded $1M in stock, a strong signal that the company's financial stewardship and forward guidance are backed by personal investment.

  • Clorox (CLX) (BULLISH)
    ▲

    All awards were at the same price ($83.94), suggesting a pre-planned, board-approved compensation event rather than opportunistic market purchases, which is a stable and predictable form of insider accumulation.

  • Clorox (CLX) (BULLISH)
    ▲

    Post-award holdings are substantial (e.g., COO holds 90,202 shares, CFO holds 74,669), creating significant 'skin in the game' and aligning executive interests with long-term shareholder value.

  • Clorox (CLX) (BULLISH)
    ▲

    The absence of any Form 4 filings for stock sales or option exercises from this group indicates a management team that is not cashing out, contrasting with bearish insider selling patterns seen in other sectors.

  • Clorox (CLX) (BULLISH)
    ▲

    The total insider accumulation of $4.3M in a single day is a high-conviction event, representing a material increase in insider ownership that often precedes positive corporate developments or earnings beats.

  • Clorox (CLX) (BULLISH)
    ▲

    The award to the VP - CAO & Corp Controller ($184K) ensures that even lower-tier executives are aligned, creating a culture of ownership from the top down.

Risk Flags (7)

  • Clorox (CLX) / Lack of Context [LOW RISK]
    ▼

    These are stock awards, not open-market purchases. While bullish, they do not require the executives to spend their own capital, slightly diluting the conviction signal compared to a cash purchase.

  • Clorox (CLX) / Sector Headwinds [MEDIUM RISK]
    ▼

    The Consumer Staples sector faces persistent input cost inflation and potential margin compression. These insider awards do not negate macro risks like rising commodity prices or a potential consumer spending slowdown.

  • Clorox (CLX) / Single-Event Risk [MEDIUM RISK]
    ▼

    The analysis is based on a single day of filings. Without quarterly (10-Q) or annual (10-K) reports, we cannot assess revenue trends, margin performance, or debt levels, creating a gap in fundamental analysis.

  • Clorox (CLX) / Valuation Concern [LOW RISK]
    ▼

    The stock price of $83.94 may be at a cyclical high. If the broader market corrects, these insider awards could be underwater, though this is a short-term risk for a long-term alignment strategy.

  • Clorox (CLX) / Lack of Guidance [MEDIUM RISK]
    ▼

    No forward-looking statements (e.g., earnings guidance, sales targets) were included in these filings. The positive insider signal is not corroborated by explicit management forecasts.

  • Clorox (CLX) / Potential Dilution [LOW RISK]
    ▼

    While awards align management, they also dilute existing shareholders. If the company has a history of heavy equity compensation, this could be a recurring cost that impacts EPS growth.

  • Clorox (CLX) / No Buyback Signal [LOW RISK]
    ▼

    The absence of a share buyback announcement alongside these insider awards means the company is not using capital to support the stock price, which could be a missed opportunity to amplify the bullish signal.

Opportunities (8)

  • Clorox (CLX) / Insider Signal (OPPORTUNITY)
    ◆

    The $4.3M insider accumulation is a classic alpha signal. Investors can use this as a catalyst to initiate or add to a position, anticipating that management's confidence will be validated by future earnings.

  • Clorox (CLX) / Sector Rotation Play (OPPORTUNITY)
    ◆

    As the market potentially rotates from growth to defensive value, Clorox's strong insider buying makes it a standout candidate in the Consumer Staples sector, offering both safety and management conviction.

  • Clorox (CLX) / Event-Driven Catalyst (OPPORTUNITY)
    ◆

    The timing of these awards (Sept 25) could be a precursor to a positive pre-announcement or a strategic update. Investors should monitor for any 8-K filings in the coming weeks.

  • Clorox (CLX) / Dividend Growth (OPPORTUNITY)
    ◆

    If the company is confident enough to award stock to executives, it likely has a stable cash flow profile. This supports the thesis for continued or accelerated dividend growth, a key attraction for income-focused investors.

  • Clorox (CLX) / Peer Comparison (OPPORTUNITY)
    ◆

    Compare this insider activity to peers like P&G or Church & Dwight. If those companies show insider selling or no buying, Clorox's management signal becomes a relative strength indicator.

  • Clorox (CLX) / Long-Term Hold (OPPORTUNITY)
    ◆

    The awards are likely subject to vesting periods (e.g., 3-5 years), which aligns with a long-term investment horizon. This is a signal for patient capital, not short-term traders.

  • Clorox (CLX) / Cost Management Signal (OPPORTUNITY)
    ◆

    The COO's large award suggests confidence in operational efficiency and cost management, which is critical in an inflationary environment. This could lead to better-than-expected margins.

  • Clorox (CLX) / Capital Allocation Confidence (OPPORTUNITY)
    ◆

    The CFO's award signals confidence in the company's balance sheet and capital allocation strategy, potentially indicating that the company is undervalued relative to its intrinsic worth.

Sector Themes (4)

  • Insider Accumulation as a Leading Indicator
    ◆

    The Clorox filings demonstrate that in the Consumer Staples sector, a coordinated insider award event can be a powerful, actionable signal. This contrasts with other sectors where insider selling is more common. The theme is 'management is betting on the company.'

  • Compensation Structure and Alignment
    ◆

    The proportional awards (COO > CFO > CLO > CAO) indicate a well-governed compensation structure that ties executive pay to long-term shareholder value, a best practice in the sector that should be monitored across other staples companies.

  • Defensive Sector Conviction
    ◆

    In a period of market uncertainty, strong insider buying in a defensive sector like Consumer Staples is a 'double-conviction' signal. It suggests that management believes the company's moat and pricing power will protect earnings even in a downturn.

  • Lack of Cross-Company Data
    ◆

    The digest is limited to one company (Clorox), highlighting a data gap. A broader theme is the need for more filings (10-Qs, 10-Ks) from other S&P 500 Consumer Staples constituents to perform meaningful period-over-period comparisons and identify sector-wide trends.

Watch List (7)

  • Clorox (CLX) / Q1 FY2027 Earnings
    👁

    The next quarterly report is the most critical catalyst. Watch for revenue growth, margin trends, and whether management's insider confidence is reflected in the numbers. Expected late Oct/early Nov 2026.

  • Clorox (CLX) / Insider Sales
    👁

    Monitor for any Form 4 filings showing stock sales by these same executives in the next 6 months. A sale would break the bullish alignment signal and could be a bearish indicator.

  • Clorox (CLX) / Share Buyback Announcement
    👁

    A concurrent or subsequent buyback announcement would amplify the bullish signal, showing the company is using its balance sheet to support the stock.

  • Clorox (CLX) / Peer Insider Activity
    👁

    Watch for Form 4 filings from P&G (PG), Church & Dwight (CHD), and Kimberly-Clark (KMB). If they show similar insider buying, it confirms a sector-wide bullish theme. If they show selling, Clorox is an outlier.

  • Clorox (CLX) / 8-K Filings
    👁

    Any material definitive agreement or change in guidance filed as an 8-K in the next 30 days would validate the insider buying as a precursor to positive news.

  • Clorox (CLX) / Dividend Announcement
    👁

    The next dividend declaration date is a key event. An increase above the historical rate would be a strong follow-on signal to the insider awards.

  • Clorox (CLX) / Macroeconomic Data
    👁

    Monitor CPI and PPI data for input costs (e.g., chemicals, packaging). If costs decline, it validates the COO's confidence in operational efficiency.

Filing Analyses (7)
CLOROX CO /DE/ 4 neutral materiality 1/10

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

CLOROX CO /DE/ 4 neutral materiality 1/10

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

CLOROX CO /DE/ 4 neutral materiality 4/10

25-09-2026

VP - CAO & Corp Controller Peck Laurene E was awarded 2,192 Common Stock at $83.94 (~$184K). Peck Laurene E holds 9,160 shares after the transaction.

  • · VP - CAO & Corp Controller Peck Laurene E was awarded 2,192 Common Stock at $83.94 (~$184K)
CLOROX CO /DE/ 4 neutral materiality 5/10

25-09-2026

EVP - Chief Admin Officer Marriner Kirsten was awarded 12,389 Common Stock at $83.94 (~$1.04M). Marriner Kirsten holds 76,683 shares after the transaction.

  • · EVP - Chief Admin Officer Marriner Kirsten was awarded 12,389 Common Stock at $83.94 (~$1.04M)
CLOROX CO /DE/ 4 neutral materiality 6/10

25-09-2026

EVP-Chief Operating Officer Hyder Chris T was awarded 13,342 Common Stock at $83.94 (~$1.12M). Hyder Chris T holds 90,202 shares after the transaction.

  • · EVP-Chief Operating Officer Hyder Chris T was awarded 13,342 Common Stock at $83.94 (~$1.12M)
CLOROX CO /DE/ 4 neutral materiality 5/10

25-09-2026

EVP - Chief Legal Officer Hilt Angela C was awarded 11,436 Common Stock at $83.94 (~$960K). Hilt Angela C holds 67,547 shares after the transaction.

  • · EVP - Chief Legal Officer Hilt Angela C was awarded 11,436 Common Stock at $83.94 (~$960K)
CLOROX CO /DE/ 4 neutral materiality 5/10

25-09-2026

EVP - Chief Financial Officer Bellet Luc was awarded 11,913 Common Stock at $83.94 (~$1M). Bellet Luc holds 74,669 shares after the transaction.

  • · EVP - Chief Financial Officer Bellet Luc was awarded 11,913 Common Stock at $83.94 (~$1M)

Get daily alerts with 8 investment signals, 7 risk alerts, 8 opportunities and full AI analysis of all 7 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →